NCT01602068View on ClinicalTrials.gov

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Cataract
Interventions
DRUG

Dexamethasone Phosphate Ophthalmic

Transcleral iontophoresis delivery of EGP-437 (dexamethasone phosphate formulated for ocular iontophoresis)

DRUG

100 mM Sodium Citrate Buffer

Transcleral iontophoresis delivery of 100 mM sodium citrate buffer solution

Trial Locations (3)

33176

Site 501, Miami

33321

Site 503, Tamarac

63090

Site 502, Washington

Sponsors
All Listed Sponsors
lead

Eyegate Pharmaceuticals, Inc.

INDUSTRY